Applied Genetic Technologies Corporation

AGTC · NASDAQ
Analyze with AI
6/30/2022
6/30/2021
6/30/2020
6/30/2019
Operating Activities
Net Income-$69-$58-$46-$2
Dep. & Amort.$2$1$1$1
Deferred Tax$0-$2$0$0
Stock-Based Comp.$3$3$3$4
Change in WC-$3$4$2-$26
Other Non-Cash$1$1-$2-$1
Operating Cash Flow-$66-$51-$42-$23
Investing Activities
PP&E Inv.-$2-$2-$1-$0
Net Acquisitions$0$0-$4$0
Inv. Purchases$0-$21-$59-$75
Inv. Sales/Matur.$2$61$73$94
Other Inv. Act.$0-$0$0-$0
Investing Cash Flow-$0$38$8$19
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$9$69$35$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$7$80$45$0
Financing Cash Flow$7$80$45$0
Forex Effect$0$0$0$0
Net Chg. in Cash-$59$67$12-$4
Supplemental Information
Beg. Cash$105$38$27$31
End Cash$46$105$38$27
Free Cash Flow-$68-$53-$43-$24